BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34951962)

  • 21. HGF/MET signaling in ovarian cancer.
    Zhou HY; Pon YL; Wong AS
    Curr Mol Med; 2008 Sep; 8(6):469-80. PubMed ID: 18781954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.
    Lee BS; Kang S; Kim KA; Song YJ; Cheong KH; Cha HY; Kim CH
    Cell Death Dis; 2014 Apr; 5(4):e1159. PubMed ID: 24722284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling.
    Wang K; Zhuang Y; Liu C; Li Y
    Arch Biochem Biophys; 2012 Oct; 526(1):38-43. PubMed ID: 22820099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma.
    Yu G; Wang Z; Zeng S; Liu S; Zhu C; Xu R; Liu RE
    Biomed Res Int; 2019; 2019():9053295. PubMed ID: 30886866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
    Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
    Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
    Crosswell HE; Dasgupta A; Alvarado CS; Watt T; Christensen JG; De P; Durden DL; Findley HW
    BMC Cancer; 2009 Nov; 9():411. PubMed ID: 19939254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.
    Ren Y; Cao B; Law S; Xie Y; Lee PY; Cheung L; Chen Y; Huang X; Chan HM; Zhao P; Luk J; Vande Woude G; Wong J
    Clin Cancer Res; 2005 Sep; 11(17):6190-7. PubMed ID: 16144920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
    Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
    Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene of the month: HGF.
    Fajardo-Puerta AB; Mato Prado M; Frampton AE; Jiao LR
    J Clin Pathol; 2016 Jul; 69(7):575-9. PubMed ID: 27072686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MET oncogene aberrant expression in canine osteosarcoma.
    Ferracini R; Angelini P; Cagliero E; Linari A; Martano M; Wunder J; Buracco P
    J Orthop Res; 2000 Mar; 18(2):253-6. PubMed ID: 10815826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.
    Bu WJ; Fang Z; Li WL; Wang X; Dong MJ; Tao QY; Zhang L; Xu YQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10452-10461. PubMed ID: 33155201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway.
    Vallet S; Bashari MH; Fan FJ; Malvestiti S; Schneeweiss A; Wuchter P; Jäger D; Podar K
    PLoS One; 2016; 11(3):e0150507. PubMed ID: 26934743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGFβ1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer.
    Breunig C; Erdem N; Bott A; Greiwe JF; Reinz E; Bernhardt S; Giacomelli C; Wachter A; Kanthelhardt EJ; Beißbarth T; Vetter M; Wiemann S
    Mol Oncol; 2018 Sep; 12(9):1447-1463. PubMed ID: 30004628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
    Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
    Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
    To CT; Tsao MS
    Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of hepatocyte growth factor and c-Met expression in extrahepatic biliary tract cancers.
    Hida Y; Morita T; Fujita M; Miyasaka Y; Horita S; Fujioka Y; Nagashima K; Katoh H
    Oncol Rep; 1999; 6(5):1051-6. PubMed ID: 10425302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Filamin a mediates HGF/c-MET signaling in tumor cell migration.
    Zhou AX; Toylu A; Nallapalli RK; Nilsson G; Atabey N; Heldin CH; Borén J; Bergo MO; Akyürek LM
    Int J Cancer; 2011 Feb; 128(4):839-46. PubMed ID: 20473907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
    Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
    Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
    Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.